Jazz Pharmaceuticals
JAZZ
JAZZ
459 hedge funds and large institutions have $8.8B invested in Jazz Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 150 increasing their positions, 145 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 452 → 459 (+7)
3% more repeat investments, than reductions
Existing positions increased: 150 | Existing positions reduced: 145
1.87% less ownership
Funds ownership: 93.83% → 91.96% (-1.9%)
Holders
459
Holding in Top 10
9
Calls
$58.7M
Puts
$47.8M
Top Buyers
| 1 | +$80.4M | |
| 2 | +$69.1M | |
| 3 | +$57.1M | |
| 4 |
SC
Samlyn Capital
New York
|
+$44.2M |
| 5 |
ACM
Atika Capital Management
New York
|
+$31M |
Top Sellers
| 1 | -$81.2M | |
| 2 | -$75.9M | |
| 3 | -$71.6M | |
| 4 |
AC
Armistice Capital
New York
|
-$63.2M |
| 5 |
HM
HealthCor Management
New York
|
-$52.9M |